Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

pharma business models

This page shows the latest pharma business models news and features for those working in and with pharma, biotech and healthcare.

A butterfly flaps its wings

A butterfly flaps its wings

And, like all environmental changes, it will create opportunities and threats for existing business models. ... This creates an opportunity for pharma and medtech business models for whom affluent consumers are the primary target market; these need not

Latest news

  • Pharma investment in marketing flat in 2013 Pharma investment in marketing flat in 2013

    Pharma investment in marketing flat in 2013. And top 10 companies reduced yearly spend on sales force and marketing channels. ... In a sign of pharma's changing business models, new data has demonstrated that the industry's investment in sales force and

  • Sex is a good trick Sex is a good trick

    Market access is a co-evolutionary problem. Payer systems and industry business models are tied together in a co-evolutionary process in which change in one is both restricted and encouraged ... But what do we observe when pharma companies try to develop

  • Hollow victory: the dangers of success Hollow victory: the dangers of success

    In our research about how pharma companies are adapting to a changing market, the capacity of firms to change is obviously an important factor. ... Even the most successful pharma companies risk being overtaken by their less successful followers .

  • Delivering 'beyond the pill' Delivering 'beyond the pill'

    They are putting pressure on the traditional models of business – pharma reps selling to script writers – and are increasingly expecting pharma to deliver a continuum of care model that delivers real ... To provide services that go beyond the pill,

  • Emerging business models for pharma Emerging business models for pharma

    Emerging business models for pharma. The traditional hegemony of the old monolithic pharma company is beginning to give way to a new, more interconnected business structure. ... Our research into evolving pharma business models reveals that the trend

More from news
Approximately 1 fully matching, plus 14 partially matching documents found.

Latest Intelligence

  • Managing medication non-adherence Managing medication non-adherence

    In this era of value-based payment models becoming mainstream, this is certainly a triple whammy of benefits for all pharma companies to aim for. ... When the business models are sufficiently attractive for the pharma companies to take notice, narrowband

  • Interview: Georg Toufar, Mundipharma Interview: Georg Toufar, Mundipharma

    There are dissenters among the pharma industry, however, with some companies learning to adapt their business strategy to this way of providing patients with medicines, rather than placing blame on a ... For Toufar, the next few years will see this

  • Proving value in uncertain times Proving value in uncertain times

    The preponderance of supply-side and demand-side controls coupled with significant budget reduction across most health economies is seriously challenging the sustainability of pharma business models and product innovation. ... Pharma does well to equip

  • Interview: Michel Goldman, Innovative Medicines Initiative Interview: Michel Goldman, Innovative Medicines Initiative

    companies, which are currently revising their business models. ... possible.". Goldman believes that the IMI is fully integrated in the pharma companies' new business models, contributing to the new ecosystem.

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

  • Mueller Hale Consulting

    We generate Pharma Business Case Models to evaluate commercial opportunities and execute strategies as project and interim managers.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is the UK arm of Zeno Group, a global integrated communications consultancy. Everything we do is rooted...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Quick links

Infographics

Multimedia